Close menu




September 29th, 2022 | 12:01 CEST

Verbio, Kleos Space, KWS Saat - This news is moving share prices!

  • Space
  • Technology
  • Investments
Photo credits: pixabay.com

Increased uncertainties in geopolitics, rampant inflation with exploding commodity and energy prices, and higher interest rates are making it increasingly difficult for companies to meet the forecasts they issued at the beginning of the year. Recent examples include battery manufacturer Varta and real estate financier Hypoport, which had to withdraw their annual targets. In addition, however, a number of companies have been able to surprise on the upside despite all the challenges.

time to read: 3 minutes | Author: Carsten Mainitz
ISIN: VERBIO VER.BIOENERGIE ON | DE000A0JL9W6 , KLEOS SPACE CDI/1/1 | AU0000015588 , KWS SAAT KGAA INH O.N. | DE0007074007

Table of contents:


    KWS Saat - Growing revenue and rising margins

    Positive news came from the plant breeding and biotechnology company KWS Saat, which was founded in Klein Wanzleben back in 1856. Despite economic and political challenges, the world's fourth-largest seed producer grew in terms of net sales from agricultural crops. According to its preliminary, unaudited results for fiscal 2021/2022, net sales rose by 17% to around EUR 1.54 billion with an EBIT margin of around 10% - that is better than expected. By comparison, EBIT in the previous year was only EUR 137 million. KWS Saat's guidance held out the prospect of net sales growth of 10% and an EBIT margin of between 8% and 9%. Given the good business performance, the Executive Board and Supervisory Board will propose to the Annual Shareholders' Meeting on December 6, 2022, that a dividend of EUR 0.80 per share be distributed.

    For the current fiscal year 2022/2023, the SDAX-listed company plans further growth with increasing profitability. Sales are expected to increase by 7% to 9% on a comparable basis. According to the Company's headquarters, the EBIT margin is expected to range between 10% and 11%.

    Eva Kienle, Chief Financial Officer, commented on the results: "Our strong growth in the past fiscal year once again underlines the attractiveness and resilience of our business model as an innovative seed company. Despite considerable burdens from inflation-related cost increases, we were able to increase our operating result significantly. In the new fiscal year, we aim to continue growing while investing at a high level in research and development as a driver of sustainable, innovative strength. However, given the existing geopolitical risks, increasing weather extremes, and strong inflationary developments, we expect the general conditions for KWS to remain challenging."

    Kleos Space - Launch in October

    Shareholders in Kleos Space, the global market leader in radio-frequency reconnaissance, have had little to cheer about in recent months. The Luxembourg-based company, which also has subsidiaries in Australia, the US and the United Kingdom, has lost around 60% of its value since the beginning of the year. Currently, a bottom is forming in the area around AUD 0.30, which could form the basis for a subsequent upward movement. The fundamental conditions for rising prices have at least been created in recent months.

    The space-based earth observation company uses space technology to locate radio transmissions around the globe and can thus efficiently analyze and uncover illegal activities on land and at sea. This involves using satellite clusters to collect radio frequency data, transmitting it to the ground, analyzing it with AI-powered technology and delivering it to the relevant customer.

    Three clusters of four satellites each are still in space, but a fourth is to follow in October with the Observer Mission (KSF3) satellites, significantly upgrading data quality. Equipped with AIS, VHF and X-band payloads, the four satellites will increase Kleos Space's data collection capacity by up to 119 million sq km per day. In addition, the average daily overflight rate over the 15-degree latitude area can be significantly increased.

    The long-term goal of the experienced management is to maneuver up to 20 clusters into orbit. Due to geopolitical tensions, the issue of security will become increasingly important with surveillance from space. States, public institutions, and private companies should rely on the technology of the market leader in the future. A growing order book already in the first half of the year is the best proof of this. The analysts at First Berlin formulate a price target of AUD 1.60 for the share certificates, a potential of over 400%!

    Verbio - Double-digit share price gain after record year

    With double-digit price gains, investors celebrated the record year of the biofuel manufacturer Verbio, which ended on June 30. The Company, based in Zörbig, Saxony-Anhalt, reported that sales in the 2021/2022 financial year rose by 77% to around EUR 1.8 billion. At around EUR 503 million, the operating result (EBITDA) was around three times higher than in the previous year. Verbio benefited from higher sales prices for biodiesel and bioethanol.

    As in the previous year, a dividend of EUR 0.20 was proposed. The Board of Directors expects to achieve EBITDA in the order of EUR 300 million in the 2022/2023 financial year. That does not take into account additional negative effects as a result of the Ukraine war.

    The analysts at Hauck Aufhäuser Investment raised the price target from EUR 85 to EUR 90 and continue to rate the share as a "buy". Verbio continues to benefit from legal requirements for the production of food-based biofuels. A tightening of the rules is unlikely in the meantime.


    Uncertainties at the economic and political levels are growing. Nevertheless, Verbio and KWS Saat both posted strong annual figures. After a significant correction, the launch of the fourth cluster into space should boost the Kleos Space share. Analysts believe the stock has great potential.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Carsten Mainitz

    The native Rhineland-Palatinate has been a passionate market participant for more than 25 years. After studying business administration in Mannheim, he worked as a journalist, in equity sales and many years in equity research.

    About the author



    Related comments:

    Commented by Juliane Zielonka on September 29th, 2023 | 07:00 CEST

    Defence Therapeutics, Schott Pharma, Allianz Group: Focus on Innovation, Growth and Portfolio Optimization

    • Biotechnology
    • Pharma
    • Investments

    According to a recent study, biotech company Defence Therapeutics achieves twice the immune response of conventional mRNA therapies with its Accum® mRNA technology. That translates to fewer side effects and a more effective treatment. According to Precedence Research, the market size for mRNA therapeutics is projected to reach approximately USD 137.59 billion by 2032. It is expected to grow at a CAGR of 13.2% from 2023 to 2032. In order to inject these active ingredients, precision-fit medical vials are required, and Schott Pharma is ensuring this with their IPO launched on the German stock exchange this week, which could bring a valuation of around EUR 4 billion. The Allianz Group, on the other hand, is focusing on consolidation, selling its business in the Middle East and thus flushing around EUR 210 million cash into its coffers.

    Read

    Commented by Stefan Feulner on September 27th, 2023 | 08:30 CEST

    AI shares in focus: C3.ai, Norcom, Amazon - Upgrade at any cost

    • Software
    • AI
    • Technology

    The implementation of generative artificial intelligence on a large scale has the potential to significantly boost the German economy, according to a study by IW Consult, conducted on behalf of Google. In this context, the comprehensive integration of programs such as ChatGPT by at least half of domestic companies could increase economic output by around EUR 330 billion. This value corresponds to almost 10% of the German gross domestic product of the previous year. This is likely to herald a quantum leap for providers of intelligent software.

    Read

    Commented by André Will-Laudien on September 27th, 2023 | 08:05 CEST

    The high-tech gold rush on the Nasdaq is waning: BYD, Manuka Resources, and Infineon remain on the buy list

    • Mining
    • Vanadium
    • Electromobility
    • Technology
    • GreenTech

    For those investing in green or high-tech sectors, keeping an eye on the supply chains of raw materials is crucial. After all, in times of geopolitical upheaval, nothing seems more important to the industry than securing its foreign sources of critical resources. The EU and the US have already responded by adding several metals to the list of strategic elements. For the capital markets, too, the fight against global warming has become an issue that cannot be ignored. We focus on successful protagonists that can enhance any portfolio.

    Read